2025 Q2 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on […]
2025 Q1 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic
China Supermarket: Is the Value for Money Due to Global Development Expertise or Superior Negotiation? Locust Walk analyzed the evolving
2024 Year-In-Review Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
2024 Q3 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
2024 Q2 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
Biopharma’s COVID Capital Comeback What a difference a few months can make – especially during a pandemic. Heading into 2020,
Strategic Implications of COVID-19 on Biopharma – March 31, 2020
2024 Q1 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
Overview of AI in Biotech Locust Walk’s Overview of AI in Biotech report discusses how AI has profoundly impacted drug